In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions. Speakers: Shannon Weatherly, Kelly Field and Zaidoon A. Al-Zubaidy

In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions. Speakers: Shannon Weatherly, Kelly Field and Zaidoon A. Al-Zubaidy

In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions. Speakers:&nbsp;Shannon Weatherly, Kelly Field and Zaidoon&nbsp;A. Al-Zubaidy

Reviewing FDA Guidelines during COVID-19

Catawba Talks is a series where we'll be talking about Catawba Research, the pharmaceutical industry and everything in between.

Share Reviewing FDA Guidelines during COVID-19

Sign up to save your podcasts

Reviewing FDA Guidelines during COVID-19

Reviewing FDA Guidelines during COVID-19